#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dent's disease Pelizaeus-Merzbacher disease Pulmonary sarcoidosis Infective uveitis Eosinophilic oesophagitis Gaucher's disease type III Neovascular age-related macular degeneration Eosinophilic granulomatosis with polyangiitis Congenital ectodermal dysplasia Metachromatic leukodystrophy Small intestine leiomyosarcoma Shprintzen-Goldberg syndrome Cytomegalovirus infection Malformation venous Spinal cord injury cervical More trials…

    Learn about Rare Diseases

    Nephroblastoma – Basic Information Usher’s syndrome Mantle cell lymphoma stage II – Life with Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Lymphangioma – Basic Information Osteosarcoma recurrent – Trials in Disease Glycogen storage disease type I – Diagnostics Congenital hypotransferrinaemia – Basic Information Alagille syndrome – Basic Information Rhabdomyosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    LY3537021 SP16 Triptorelin Glucocorticoids 4-IODOPHENYLALANINE I-131 Mrna-4157 RPTR-1-201 Eftilagimod Alfa Eclitasertib Cx-039776 Tivozanib Pristinamycin Aztreonam Bendamustine Folic Acid, Anhydrous Tolinapant Lactate Ubiquinol Xp-Dc+Tl+Klh Iptacopan Hydrochloride Pyrimethamine More therapies…

    Learn about Your Condition

    Adrenocortical carcinoma Cirrhosis alcoholic Gastrointestinal melanoma Colon cancer stage II Vomiting Osteosarcoma Colon cancer stage IV Synovial sarcoma metastatic Crigler-Najjar syndrome Richter's syndrome Cleft lip and palate Glanzmann's disease Cardiac failure Basal cell naevus syndrome Gastrointestinal disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Therapeutics

  • Study on the Effect of Levobupivacaine in Reducing Chronic Pain After Open Inguinal Hernia Repair in Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Abdominal pain
    • Abdominal wall pain
    • Hernia repair
    Spain

  • Study on Preventing Cytomegalovirus Infection Using Valganciclovir in Kidney Transplant Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Valganciclovir
    France

  • Study of Semaglutide for Weight Loss in Obesity Patients with Low Response After Bariatric Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Semaglutide
    The Netherlands

  • Study of personalized rituximab dosing using artificial intelligence in patients with membranous nephropathy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glomerulonephritis acute
    Investigated Drugs:
    • Rituximab
    France

  • Study of Ipilimumab, Nivolumab and Melphalan combination therapy with hepatic perfusion in patients with advanced uveal melanoma that has spread to other organs

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Uveal melanoma
    Investigated Drugs:
    • Melphalan
    • Ipilimumab
    • Nivolumab
    The Netherlands

  • Oxygen Therapy to Prevent Breathing Problems After Non-Cardiac Surgery in Patients at Risk for Postoperative Complications

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypoxia
    • Oxygen saturation
    • Oxygen therapy
    Investigated Drugs:
    • Oxygen
    Austria
Previous Page
1 … 4 5 6 7 8 … 24
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!